4.6 Article

Direct cyclodextrin-based powder extrusion 3D printing for one-step production of the BCS class II model drug niclosamide

期刊

DRUG DELIVERY AND TRANSLATIONAL RESEARCH
卷 12, 期 8, 页码 1895-1910

出版社

SPRINGER HEIDELBERG
DOI: 10.1007/s13346-022-01124-7

关键词

Three-dimensional printing; Direct powder extrusion printing; 3DForMe printer; Repositioning niclosamide; Personalized medicines; Amorphous solid dispersions; Hydroxypropyl-beta-cyclodextrin

资金

  1. M.I.U.R-Programma Operativo Nazionale 2014-2020
  2. Azione: l.1-Dottorati di ricerca innovativi 2020
  3. European Union [768775]
  4. H2020 Societal Challenges Programme [768775] Funding Source: H2020 Societal Challenges Programme

向作者/读者索取更多资源

This study successfully printed tablets containing Niclosamide using the direct powder extrusion 3D printing technique. This innovative method overcomes the limitations of previous techniques and demonstrates the potential to produce personalized pharmaceutical forms directly from powders. The tablets showed good characteristics in terms of solubility, drug release, stability, and mechanical properties.
Niclosamide (NCS) is a drug that has been used as an anthelmintic and anti-parasitic drug for about 40 years. Recently, some studies have highlighted its potential in treating various tumors, allowing a repositioning of this drug. Despite its potential, NCS is a Biopharmaceutical Classification System (BCS) Class II drug and is consequently characterized by low aqueous solubility, poor dissolution rate and reduced bioavailability, which limits its applicability. In this work, we utilize a very novel technique, direct powder extrusion (DPE) 3D printing, which overcomes the limitations of previously used techniques (fused deposition modelling, FDM) to achieve direct extrusion of powder mixtures consisting of NCS, hydroxypropyl methylcellulose (HPMC, Affinisol 15 LV), hydroxypropyl-beta-cyclodextrin (HP-beta-CD) and polyethylene glycol (PEG) 6000. For the first time, direct printing of powder blends containing HP-beta-CD was conducted. For all tablets, in vitro dissolution studies showed sustained drug release over 48 h, but for tablets containing HP-beta-CD, the release was faster. Solid-state characterization studies showed that during extrusion, the drug lost its crystal structure and was evenly distributed within the polymer matrix. All printed tablets have exhibited good mechanical and physical features and a stability of the drug content for up to 3 months. This innovative printing technique has demonstrated the possibility to produce personalized pharmaceutical forms directly from powders, avoiding the use of filament used by FDM.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据